Breast Cancer in Thailand
According to National Cancer Institute, Breast cancer is the most common cancer among Thai women with an estimated incidence rate of approximately 40. Over the past decade, the incidence of breast cancer in Thailand has been steadily increasing. Although the rate of breast cancer was relatively high among 45–50-year-old women, of late there is also a high incidence of breast cancer among younger women. (Source: Insamran W, Sangrajrang S. National cancer control program of Thailand. Asian Pac J Cancer Prev 2020;21:577-82.)
The most common histological type is ductal carcinoma, accounting for the majority of cases in all regions of Thailand. Ductal carcinoma is the predominant histological subgroup of breast cancer in Thailand, comprising between 76.4% and 91.2% of cases. Other histological types are less common, with lobular carcinoma representing 0% to 6.4% of cases. (Source: Cancer in Thailand Volume IX)
It is important to screen early and act early. There are many advantages of early detection and the peace of mind that comes with a screening. Early detection of breast cancer can significantly increase the chances of successful treatment and survival. According to the Ministry of Public Health, Thailand the survival rates for breast cancer patients vary by stage. Hence, it is important to screen regularly and take prompt action in the face of potential symptoms.
Our Contribution
This October, Lotus Azure offers FREE screening to promote breast cancer awareness and early detection:
- Clinical Breast Examination: A professional examination to check for any abnormalities in breast tissue.
- BMI Analysis: An assessment of body mass index to evaluate weight-related health risks.
- Diabetes Test: A screening to identify potential diabetes risk factors.
- Blood Pressure Check: Monitoring blood pressure to detect hypertension.
CTA Button here: Book your Free Screening Now
Additionally, women can take advantage of the CA 15-3 marker test at a privileged price of ฿ 1199, which helps in monitoring breast cancer progression.